Adial Pharmaceuticals, Inc - Common Stock — Cash Flow (NASDAQ:ADIL) | MetaTrader

Open full chart Full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -7.63 M-11.95 M-11.19 M-6.81 M-6.92 M-6.49 M -6.52 M Cash from investing activities -350 K-34.02 K01.5 M0150 K 0 Cash from financing activities 5.61 M13.64 M9.13 M4.13 M7.85 M8.47 M 8.74 M Free cash flow -7.63 M-11.95 M-11.19 M-6.81 M-6.92 M-6.49 M -6.52 M

News

Adial Pharmaceuticals Lead Drug Fits New Policy Mood As Bipartisan Bill Signals Broader Lens On Alcohol Use Disorder - Adial Pharmaceuticals (NASDAQ:ADIL)

Adial Pharmaceuticals signs framework deal with Molteni for Europe

EXCLUSIVE: Adial Pharma Eyes Europe Deal For Lead Drug For Alcohol Use Disrder Worth Up To $60 Million - Adial Pharmaceuticals (NASDAQ:ADIL)

Adial Pharmaceuticals stock rises on FDA policy shift

Adial Pharmaceuticals eyes single pivotal trial path for AD04

Morning News Wrap-Up: Thursday’s Biggest Stock Market Stories! - TipRanks.com

Adial Pharmaceuticals stock tumbles after announcing 1-for-25 reverse split

Adial Pharmaceuticals announces 1-for-25 reverse stock split

Adial Pharmaceuticals announces resignation of board member James W. Newman, Jr.

Has Acurx Pharmaceuticals (ACXP) Outpaced Other Medical Stocks This Year?

Adial Pharmaceuticals raises $2.86 million through warrant exercise

Adial completes key validation for alcohol disorder treatment test